DNA methylation status of dapk and MT1G genes in diffuse large B-cell lympihoma and its clinical relevance / Samir Ahmed Shawky ; Supervised Mohamed H. Elborai , Hussein M. Khaled , Abeer Ahmad Bahnassy
Material type:
- دراسة نسق إضافة مركب الميثيل إلى الحامض النووى الديؤكسى ريبوزى فى الجينين (دى أ بى كا) و (م ت ١ جى) فى حالات سرطان الجهاز الليمفاوى (بى) ذو الخلايا الكبيرة و أهميته الأكلينيكية [Added title page title]
Item type | Current library | Home library | Call number | Status | Barcode | |
---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.Ph.D.2012.Sa.D (Browse shelf(Opens below)) | Not for loan | 01010110062519000 |
This thesis arrived by email without CD
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Pathology
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of of Non-hodgkin's lymphoma (NHL) and can be divided into prognostically important subgroups with germinal center B-cell-like (GCB) and non-GCB subtypes either by using cDNA microarray or immunostains (CD10, BCL6, MUM1). Beyond genetic alterations, identification of novel epigenetic alterations, such as aberrant methylation may yield better diagnostic, prognostic and therapeutic information
There are no comments on this title.